Home/Chronic Disease/Chronic Kidney Disease
🫘
Kidney Disease

Chronic Kidney Disease

Protecting Your Kidneys — Slowing Progression, Preserving Function

Understanding Chronic Kidney Disease

Chronic kidney disease (CKD) is a progressive condition in which the kidneys gradually lose their ability to filter waste and fluid from the blood. It affects about 15% of US adults. The most common causes are diabetes and hypertension — two conditions that damage the delicate filtering units of the kidneys over time. CKD is classified in stages 1–5 based on kidney function (GFR), with stage 5 representing kidney failure requiring dialysis or transplant. Early detection and management can dramatically slow or halt progression.

Signs & Symptoms

  • Often no symptoms in early stages
  • Fatigue and weakness
  • Swelling in ankles, feet, or around the eyes
  • Decreased urine output or changes in urination
  • Shortness of breath
  • Nausea and loss of appetite
  • Itching
  • High blood pressure (both a cause and symptom)

Our Management Approach

CKD management in primary care focuses on slowing progression, managing complications, and protecting cardiovascular health. We monitor your kidney function with regular labs (creatinine, GFR, urine albumin), optimize blood pressure and blood sugar control, adjust or avoid nephrotoxic medications, and coordinate nephrology referral when appropriate.

1
Kidney Function Monitoring
Regular creatinine, eGFR, and urine albumin-to-creatinine ratio (UACR) to track progression.
2
Blood Pressure Control
Target below 130/80 mmHg; ACE inhibitors and ARBs provide kidney-protective benefits beyond blood pressure lowering.
3
Blood Sugar Management
Tight glycemic control in diabetic CKD; SGLT2 inhibitors (empagliflozin, dapagliflozin) have proven kidney-protective effects.
4
Medication Safety
Reviewing and adjusting medications that are nephrotoxic (NSAIDs, contrast dye, certain antibiotics) based on kidney function stage.
5
Nephrology Coordination
Timely referral to nephrology for stage 3b–5 CKD, rapidly declining function, or complex management needs.

Treatment Goals

  • Slow or halt GFR decline
  • Reduce urine protein (albuminuria)
  • Blood pressure below 130/80 mmHg
  • Prevent uremic complications
  • Avoid progression to dialysis for as long as possible

Lifestyle Recommendations

  • •Low-sodium diet: reduces blood pressure and protein loss
  • •Protein-moderate diet: in advanced CKD, excess protein worsens kidney stress
  • •Low potassium and phosphorus diet in stages 3–5
  • •Stay well hydrated unless on fluid restriction
  • •Avoid NSAIDs (ibuprofen, naproxen) — they worsen kidney function
  • •Exercise regularly to manage blood pressure and blood sugar
  • •Avoid contrast dyes without proper kidney precautions

Medications & Treatment Options

  • 💊Blood pressure: ACE inhibitors (lisinopril, enalapril) or ARBs (losartan, valsartan) — first-line for renal protection; target <130/80 mmHg
  • 💊SGLT2 inhibitors: empagliflozin (Jardiance), dapagliflozin (Farxiga) — slow GFR decline in CKD; approved for all stages, even without diabetes
  • 💊GLP-1 agonists: semaglutide, dulaglutide — cardiovascular and renal protection in CKD with diabetes
  • 💊For proteinuria refractory to ACEI/ARB: finerenone (kerendia) — non-steroidal aldosterone antagonist, reduces proteinuria and GFR decline
  • 💊Other: potassium binders (sodium zirconium cyclosilicate/Lokelma) if hyperkalemia; phosphate binders (calcium acetate, sevelamer) in stages 4–5

Monitoring Schedule

Baseline: creatinine, eGFR (using race-free CKD-EPI 2021), UACR, potassium, phosphorus. Frequency: eGFR every 3–6 months if stable, more frequent if declining; UACR annually; electrolytes every 3 months on ACEI/ARB; monitor BP at home

Clinical Protocol

CKD stage by eGFR: Stage 1 (≥90, albuminuria present), Stage 2 (60–89, albuminuria), Stage 3a (45–59), Stage 3b (30–44), Stage 4 (15–29), Stage 5 (<15). All patients: ACE-I or ARB (preferred); if diabetic or albuminuria: add SGLT2i (empagliflozin/dapagliflozin). If continued proteinuria on dual therapy: add finerenone. Screen for anemia (target Hgb 10–11.5 in CKD), manage phosphate/calcium in stages 4–5, vaccinate against COVID/flu/pneumococcal. Refer to nephrology: eGFR <30, rapidly declining eGFR (>4 mL/min/year), resistant hypertension, unusual proteinuria pattern, or recurrent AKI.

When to Seek Urgent Care

  • →Sudden significant decrease in urine output
  • →Severe swelling in legs, face, or abdomen
  • →Shortness of breath at rest
  • →Confusion or severe fatigue
  • →Blood in urine

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Individual treatment plans vary. Always consult your healthcare provider before starting, stopping, or changing any medication or treatment.

Managing Kidney Disease?

Book a telehealth visit with Pineapple Primary Care to get a personalized chronic kidney disease management plan.

Book an Appointment

Quick Facts

  • ✓Slow or halt GFR decline
  • ✓Reduce urine protein (albuminuria)
  • ✓Blood pressure below 130/80 mmHg
← Back to Chronic Disease Management